Low cell density in cataract surgery remains a challenge

Can patients' vision improve from cataract surgery alone?

Low cell density in cataract surgery remains a challenge
Dermot McGrath
Dermot McGrath
Published: Sunday, September 15, 2019
[caption id="attachment_16666" align="alignleft" width="1024"] Vincenzo Scorcia[/caption] Cataract surgery in cases of low endothelial cell density remains a challenging proposition even for more experienced surgeons, according to Vincenzo Scorcia MD. “It makes it a difficult decision for the surgeon to decide whether to proceed with cataract surgery alone or to combine it with keratoplasty,” he told delegates attending the joint ESCRS/EuCornea Symposium at the 37th ESCRS Congress. Dr Scorcia said that there are several issues to be addressed before embarking on cataract removal in patients with pathologies such as Fuchs’ endothelial dystrophy or those who had previously undergone penetrating keratoplasty. “We need to ask if the patient could improve their vision from cataract surgery alone. We also need to assess the risk of corneal decompensation after cataract surgery and determine which preoperative parameters should be considered as risk factors for corneal failure,” he said. Up to 90% of Fuchs’ patients who underwent cataract surgery did not need corneal transplants and achieved a postoperative best-corrected visual acuity of 20/35, said Dr Scorcia. “In a large number of cases, opting for cataract extraction alone despite endothelial pathology may be a good option because the patients are often satisfied with less than perfect visual outcomes and it avoids the potential complications associated with endothelial keratoplasty,”  he said.  
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...